Research: Dr. Beutler has identified several natural products which have potential for development as cancer drug; among them are englerins, in preclinical development for kidney cancer and Ewing’s sarcoma, schweinfurthins, which are preclinical candidates in glioblastoma and malignant peripheral nerve sheath tumors, and salicylihalamides, of interest in sarcomas.
Education: B.A., Chemistry, Vassar College, 1972
M.Sc., Philadelphia College of Pharmacy & Science, 1978
Ph.D., Philadelphia College of Pharmacy & Science, 1980
Postdoctoral Fellowships: Northeastern University, 1980-1, University of Texas Medical School at Houston, 1983-4
Assistant Professor, Auburn University School of Pharmacy, 1981-1983
NCI-Frederick 1984-current
ASP President 2010-2011
AAAS Fellow, 2019